We are live on ! Find out more
QM

QVIDTVM Management Portfolio holdings

AUM $76.6M
1-Year Est. Return 33.48%
This Fund
S&P 500
This Quarter Est. Return
-0.69%
1 Year Est. Return
+33.48%
3 Year Est. Return
+19.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$10M
Cap. Flow
-$3.93M
Cap. Flow %
-3.31%
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
6
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$17.5M
2
RTO icon
Rentokil
RTO
+$5.46M
3
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
+$2.76M
4
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
+$446K
5
HLN icon
Haleon
HLN
+$412K

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$17.3M
2
DOCU
DocuSign
DOCU
+$5.61M
3
VSXY
Victoria's Secret
VSXY
+$5.35M
4
WAB icon
Wabtec
WAB
+$2.71M

Sector Composition

Rank Sector Weight
1 Industrials 43.61%
2 Healthcare 41.06%
3 Consumer Staples 7.93%
4 Technology 7.4%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIO icon
1
Bio-Rad Laboratories Class A
BIO
$10.3B
$40.4M 34%
125,038
+55,867
+81% +$17.5M
WAB icon
2
Wabtec
WAB
$47.8B
$27.2M 22.9%
214,275
-24,000
-10% -$2.71M
RTO icon
3
Rentokil
RTO
$12B
$24.5M 20.66%
857,448
+186,043
+28% +$5.46M
BRCC icon
4
BRC Inc
BRCC
$125M
$9.42M 7.93%
259,428
+11,693
+5% +$403K
DOCU
5
DocuSign
DOCU
$13.1B
$8.79M 7.4%
147,870
-122,330
-45% -$5.61M
HLN icon
6
Haleon
HLN
$42.2B
$6.25M 5.26%
759,564
+50,000
+7% +$412K
MRVI icon
7
Maravai LifeSciences
MRVI
$1.09B
$1.07M 0.9%
163,230
– –
OMIC
8
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$1.07M 0.9%
77,321
+37,708
+95% +$446K
FTCH
9
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$64K 0.05%
3,201,461
+1,800,877
+129% +$2.76M
VSXY
10
Victoria's Secret
VSXY
$6.01B
– –
-320,451
Closed -$5.35M
CTLT
11
DELISTED
CATALENT, INC.
CTLT
– –
-378,991
Closed -$17.3M

Similar funds

SWM
Stapp Wealth Management Olympia, Washington $76.5M AUM 21.17% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
MA
McGrath & Associates Asheville, North Carolina $76.8M AUM 22.42% 1-Year Est. Return
PWS
Pursuit Wealth Strategies Raleigh, North Carolina $76.9M AUM
SPC
Square Peg Capital Surry Hills, NSW, Australia $76.2M AUM 9.17% 1-Year Est. Return
SRA
Summit Rock Advisors New York $76.1M AUM
BC
Bayhunt Capital Mill Valley, California $77.1M AUM
VIM
VCU Investment Management Richmond, Virginia $77.1M AUM

QVIDTVM Management's Q4 2023 Portfolio in Review

As of Q4 2023, QVIDTVM Management held 11 positions worth $119M, down 7.8% from $129M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

QVIDTVM Management withdrew a net $3.93M in Q4 2023, closing 2 positions and reducing 2 holdings. Its most notable exit was CATALENT, INC., an estimated $17.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 44% of assets, up from 41% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, QVIDTVM Management added an estimated $17.5M to Bio-Rad Laboratories Class A.

  • QVIDTVM Management added most to Bio-Rad Laboratories Class A in Q4 2023, an estimated $17.5M increase.
  • QVIDTVM Management's biggest Q4 2023 reduction was DocuSign, cutting an estimated $5.61M.
  • QVIDTVM Management fully exited CATALENT, INC. in Q4 2023, selling an estimated $17.3M.
  • QVIDTVM Management's ten largest holdings make up 100% of its $119M portfolio in Q4 2023.
  • QVIDTVM Management opened 0 new positions and closed 2 in Q4 2023.
  • QVIDTVM Management's portfolio value fell 7.8% quarter-over-quarter to $119M.

Based on QVIDTVM Management's 13F filing for Q4 2023, filed 13 Feb 2024.